Single answer
Is Amyris Inc (AMRS) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
No analyst target data available for this ticker.
Company snapshot
A quick overview of the business and its public profile.
Amyris Inc a synthetic biotechnology company operates in the clean health and beauty and flavors and fragrance markets in Europe North America Asia and South America The company manufactures and sells clean beauty personal care and health and wellness consumer products as well as ingredients to the flavor and fragrance nutrition food and beverage and clean beauty and personal care end markets It offers its products under the Biossance Pipette Purecane Terasana Costa Brazil OLIKA Rose Inc and JVN brand names The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID19 vaccine The company was formerly known as Amyris Biotechnologies Inc and changed its name to Amyris Inc in June 2010 Amyris Inc was incorporated in 2003 and is headquartered in Emeryville California
Website: httpsamyriscom
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 1.19. Cash flow to debt ratio: -0.54. Net profit margin: -198.60%. Inflation risk score: high (1.00/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Amyris Inc is $4.7M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On Amyris Inc, 2015-12-31 had a stock price of $24.30. If you invested back then, your return now would be a loss of $24.25 per share or 99.79%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.
No analyst target data available for this ticker.